research use only

Brequinar Sodium Dehydrogenase inhibitor

Cat.No.S3565

Brequinar Sodium (Bipenquinate, BRQ, DUP-785, NSC 368390) is a potent and selective dihydroorotate dehydrogenase (DHODH) inhibitor with IC50 of ~20 nM and triggers differentiation in the ER-HoxA9, U937, and THP1 cells with ED50 of ~1 μM.
Brequinar Sodium Dehydrogenase inhibitor Chemical Structure

Chemical Structure

Molecular Weight: 397.35

Quality Control

Chemical Information, Storage & Stability

Molecular Weight 397.35 Formula

C23H14F2NNaO2

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 96201-88-6 -- Storage of Stock Solutions

Synonyms Bipenquinate, BRQ, DUP-785, NSC 368390 Smiles CC1=C(C(=O)O[Na])C2=CC(=CC=C2N=C1C3=CC=C(C=C3)C4=C(F)C=CC=C4)F

Solubility

In vitro
Batch:

DMSO : 79 mg/mL (198.81 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : Insoluble

Ethanol : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Targets/IC50/Ki
DHODH [1]
(Cell-free assay)
20 nM
References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT05945251 Recruiting
Functional Abdominal Pain Syndrome
Karolinska Institutet|Child and Adolescent Psychiatry Stockholm
November 1 2023 --
NCT04294420 Completed
Functional Gastrointestinal Disorders
Karolinska Institutet
May 1 2020 Not Applicable
NCT03252743 Completed
Functional Gastrointestinal Disorders|Irritable Bowel Syndrome|Dyspepsia|Functional Abdominal Pain
Karolinska Institutet
September 1 2017 Not Applicable
NCT02873078 Completed
Functional Abdominal Pain Disorders
Karolinska Institutet
August 2016 Not Applicable
NCT02475096 Completed
Functional Gastrointestinal Disorders
Karolinska Institutet
July 2015 Not Applicable

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Signaling Pathway Map